ABVC BioPharma Inc

ABVCNASDAQ · USD
1.16USD+0.01 (+0.78%)
112

ABVC BioPharma Inc (ABVC) Option Chain

As of September 17, 2026, ABVC BioPharma Inc is trading at $1.16, a +0.78% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 299.8%. IV Rank is 37%.

Read more

Tracking the ABVC option chain helps you see every strike and expiry on ABVC BioPharma Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. ABVC BioPharma Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABVC options activity at a glance. Use our scanner to monitor the ABVC option chain in real time and filter for the ABVC options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABVC stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ABVC option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ABVC stock options are being actively traded and where they are not.

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage.

It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls ABVC BioPharma Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ABVC options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ABVC stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile30.56% Subdued
  • Market cap (M$)36
  • 52 weeks high-66.18%
  • 52 weeks low61.97%
  • Analyst recommendation
  • Target price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-16
  • P/E
  • Future P/E
  • EPS (ttm)-0.29
  • EPS growth next 5 years

As of September 17, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
Loading option chain…

As of September 17, 2026

Scan the full option chain in one place

Browse the full ABVC option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial